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The role of ultrasonographic hepatic artery resistive index
in the diagnosis of insulin resistance in obese children with
non-alcoholic fatty liver disease
Şamil HIZLI1, Ali KOÇYİĞİT2, Nur ARSLAN3, Sedat TUNCEL2, Fatih DEMİRCİOĞLU3,
Handan ÇAKMAKÇI2, Benal BÜYÜKGEBİZ4

Aim: To determine the role of hepatic artery resistive index (HARI) measurement in the prediction of insulin resistance
(IR) in obese children with nonalcoholic fatty liver disease (NAFLD).
Materials and methods: A total of 64 obese subjects with NAFLD (13.5 ± 1.36 years of age, 34 male) and 32 age- and
gender-matched control subjects (13.8 ± 1.24 years of age, 16 male) were enrolled in the study. All subjects underwent a
physical examination, laboratory tests, and ultrasonographic and Doppler examinations of the liver. The homeostasis
model assessment of IR (HOMA-IR) was used for the IR diagnosis.
Results: Obese subjects with NAFLD had significantly higher HARI, insulin, alanine aminotransferase (ALT), total
cholesterol (TC), triglycerides (TG), and HOMA-IR than the control subjects. Obese subjects with NAFLD and IR had
significantly higher HARI compared to obese subjects with NAFLD but without IR (0.761 ± 0.04 vs. 0.732 ± 0.04, P =
0.006). Changes in HARI correlated significantly to changes in BMI, SDS-BMI, MAC, TSF, MAC, ALT, TC, insulin, and
HOMA-IR (r = 0.578, P = 0.001; r = 0.547, P = 0.001; r = 0.549, P = 0.001; r = 0.504, P = 0.001; r = 0.549, P = 0.001; r =
0.223, P = 0.029; r = 0.306, P = 0.002; r = 0.315, P = 0.011; r = 0.295, P = 0.018, respectively). As an optimal cutoff point,
a HARI level of 0.715 determined IR with 81.2% sensitivity and 71.9% specificity.
Conclusion: Our findings suggest that HARI might be used as a simple and non-invasive screening method to predict
IR in obese children with NAFLD.
Key words: Obesity, insulin resistance, nonalcoholic fatty liver disease, hepatic artery resistive index, adolescent, Doppler
ultrasonography

Non-alkolik yağlı karaciğer hastalığı olan obez çocuklarda insulin rezistansının
belirlenmesinde ultrasonografik hepatik arter rezistif indeksinin rolü
Amaç: Bu çalışmanın amacı non-alkolik yağlı karaciğer hastalığı olan obez çocuklarda insülin rezistansının (IR)
belirlenmesinde ultrasonografik hepatik arter resistif indeksi (HARI) ölçümünün yerinin değerlendirilmesidir.
Yöntem ve gereç: Non-alkolik yağlı karaciğer hastalığı tanısı almış olan toplam 64 obez çocuk (13,5 ± 1,36 yıl, 34 erkek)
ile yaş ve cinsiyet açısından farklı olmayan 32 çocuk (13,8 ± 1,24 yıl, 16 erkek) kontrol olarak alındı. Tüm çocuklar fizik
inceleme, laboratuar testleri, ultrasonografi ve Doppler ile değerlendirildi. IR tanısı koymak için insülin rezistansı
homestaz modeli değerlendirme (HOMA-IR) yöntemi kullanıldı.
Bulgular: Non-alkolik yağlı karaciğer hastalığı olan obez çocukların HARI, insülin, alanin aminotransferaz (ALT), total
kolesterol (TC), trigliserit (TG) ve HOMA-IR değerleri kontrol hastalarından yüksekti (P < 0,05). Non-alkolik yağlı
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karaciğer hastalığı ve IR olan obez çocukların HARI ölçümleri IR saptanmayanlardan yüksekti (sırasıyla 0,761 ± 0,04 ve
0,732 ± 0,04, P = 0,006). HARI değişiklikleri beden kitle indeksi (BKİ), BKİ-SDS skoru, glukoz, ALT, TC, TG ve HOMAIR değerlerinin önemli korelasyonu vardı (sırasıyla; r = 0,578, P = 0,001; r = 0,547, P = 0,001; r = 0,549, P = 0,001; r =
0,504, P = 0,001; r = 0,549, P = 0,001; r = 0,223, P = 0,029; r = 0,306, P = 0,002; r = 0,315, P = 0,011; r = 0,295, P = 0,018).
HARI ölçümünün 0,715 ve üzerinde saptanması insülin rezistansını % 81,2 duyarlılık ve % 71,9 özgüllükte gösteriyordu.
Sonuç: Bulgularımız non-alkolik yağlı karaciğer hastalığı olan obez çocuklarda HARI ölçümünün IR tanısının
belirlenebilmesi için tarama amaçlı kullanılabilecek basit ve noninvazif bir tetkik olabileceğini düşündürmüştür.
Anahtar sözcükler: Obezite, insulin rezistansı, non-alkolik yağlı karaciğer hastalığı, hepatik arter rezistif indeksi,
adölesan, doppler ultrasonografi

Introduction

Subjects and methods

Nonalcoholic fatty liver disease (NAFLD) is a
very frequent condition that is most commonly a
complication of obesity and has been shown to be
increasing all over the world both in adult and
pediatric populations (1-3). NAFLD starts as fatty
liver and may progress to nonalcoholic
steatohepatitis (NASH). NASH is an inflammatory
form of NAFLD that can progress to fibrosis,
cirrhosis, and even to hepatocellular carcinoma (4).
Insulin resistance (IR), which is detected by HOMAIR, has been found to be strictly related with NASH
pathogenesis (5,6). IR plays a pivotal role through
oxidative stress, leading to endothelial dysfunction
inflammatory changes in the microvasculature (7).
Clinical examinations and biochemical laboratory
tests including transaminases are unreliable in
differentiating NASH progression and risk
stratification. Liver histology is considered the gold
standard for diagnosis of NASH but liver biopsy is
associated with risks of complications, patient
discomfort, and expense (8-11). Therefore, tracking
of NASH progression and complication development
cannot rely on repeated biopsies (11).

This was a case-control study conducted in
adolescents diagnosed as obese and IR in Dokuz Eylül
University Department of Pediatric Gastroenterology
and Nutrition. A total of 64 obese subjects with
NAFLD (13.5 ± 1.36 years of age; 30 female and 34
male patients) and 32 age- and gender-matched lean
subjects (13.8 ± 1.24 years of age; 16 female and 16
male subjects) were included in this study. Age- and
gender-matched children admitted due to mild
dyspepsia without obesity (SDS BMI < +1 SD for age
and gender) and normal liver at US were included in
the study as controls.

Hepatic artery resistive index (HARI) is a Doppler
ultrasonography parameter that is used to follow up
microcirculatory resistance in fatty liver, adult
alcoholic liver disease, chronic hepatitis, and posttransplant liver patients and in children with severe
cirrhosis secondary to biliary atresia (12-18).
The relation of HARI with HOMA-IR has not
been explored in obese adolescents with NAFLD and
there is no cut-off point of HARI to detect IR yet. The
aim of this study was to determine the relation of
HARI with HOMA-IR and the threshold value of
HARI to detect IR in obese adolescents with NAFLD.
336

Body size measurements were obtained in the
standing position with the head and eyes directed
forward and the upper limbs hanging by the sides.
Height was measured in stocking feet to the nearest
millimeter. Body weight was recorded using calibrated
scales in light clothing to the nearest 0.1 kg. Height
and body weight measurements were taken twice and
the mean of the 2 readings was calculated. Triceps
skinfold thickness was measured by a single observer
using a Holtain (Crymych, UK) skinfold caliper. Each
patient was measured 3 times; the average of the
measurements was recorded. In addition, midarm
circumference was measured with the measuring tape
kept horizontal. BMI of patients was calculated
according to the formula kg m2 (19). The criterion for
diagnosing obesity was defined according to the
World Health Organization classification as the body
mass index standard deviation score (SDS-BMI)
being over +2 SD of the same gender and age (WHO)
(19,20).
A detailed history was obtained and a physical
examination (including evaluation for syndromes and
endocrine pathologies) was performed in all subjects.
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Figure 1. Hepatic artery resistive index of control, and obese with
NAFLD with IR and without IR groups.

Figure 2. Hepatic artery resistive index of control and obese with
NAFLD groups.

None of the subjects was taking drugs or had a history
or evidence of metabolic, cardiovascular, respiratory
or hepatic disease, and laboratory evaluation (thyroid
function tests and diurnal variation of cortisol). The
children with syndromal and endocrine causes
(Cushing’s syndrome, complete gonadal dysgenesis,
hypothyroidism, etc.) of obesity were excluded.

Before the ultrasound examination, the subjects
were instructed to rest quietly in a temperaturecontrolled dark room for 10 to 15 min. All HARI
measurements were made by the same radiologist,
who was blinded to the clinical and laboratory data of
the patients. All subjects were examined at 1200 after
12 h of fasting in order to avoid the prandial effect.
Convex transducers with frequency of 2-5 MHz were
used for the Doppler US examination (ATL HDI
5000-Philips Medical Systems, Bothell, WA, USA).
Doppler US evaluations of the hepatic artery of
patients and controls were performed after lying for
15 min in the supine or left posterior oblique position
during deep inspiration. The Doppler angle was set at
60° during spectral analysis. The HARI result of each
subject was calculated as the mean of 3 measurements
made automatically by US machine using the
following formula: [(hepatic artery peak systolic flow
– hepatic artery end diastolic flow) / hepatic artery
peak systolic flow]. The hepatic artery was examined
at the point where it crosses the portal vein and HARI
measurements were done as previously described (1618). Hepatic steatosis was investigated by US and
presented as positive or negative. Presence of hepatic
steatosis was confirmed by another radiologist, who
was uninformed about HARI measurements.

Biochemical tests of patients were performed after
12 h of fasting. Venous blood samples were obtained
to measure plasma glucose and insulin levels in the
morning at 0800 by venipuncture after overnight
fasting. After clotting, the serum was separated and
immediately explored for analyses. Levels were
measured for fasting serum glucose, alanine
aminotransferase (ALT), total cholesterol (TC), and
triglycerides (TG) by enzymatic colorimetric method.
Plasma liver tests were determined by standard
laboratory procedures. Serum-fasting glucose, TC, and
TG levels were measured. Normal ranges for serum
aminotransferase levels, in our laboratory, were 5 to 45
U/L for children. Hepatotropic viruses, serum copper
and ceruloplasmin levels, serum α1-antitrypsin level,
and autoantibodies against nuclear, smooth muscle,
liver, and kidney microsomal type-1 antigens were
screened to eliminate infectious, metabolic, and
immunological liver pathologies. IR was estimated
using the homeostasis model assessment for IR
(HOMA-IR; fasting insulin X fasting glucose/22.5) and
equal or greater than 4 was accepted as IR for pubertal
subjects (HOMA-IR ≥ 4) (21).

Statistical Analyses
SPSS (version 16.01 for Windows; SPSS Inc.,
Chicago, IL, USA) was used for statistical analyses.
The data were expressed as mean ± SD for numerical
337
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variables and as percentages (%) for categorical
variables. A P value of less than 0.05 was considered to
be statistically significant. We compared the
differences in variables between control subjects and
obese subjects with and without IR with Student’s ttest compared after ascertaining that the data were
normally distributed. A chi-squared test was used for
comparing percentages. The cut-off point of HARI to
determine IR was evaluated by Receiver Operating
Characteristics (ROC) analysis. Then sensitivity,
specificity, positive and negative predictive values, and
diagnostic accuracy of this cut-off point were
calculated.
The study conformed to the guidelines established
in the Helsinki Declaration II. The local ethics
committee of the University approved the study
protocol and informed consent was obtained from the
study subjects. No complications or side effects were
encountered.

Results
The clinical and laboratory characteristics of the
control subjects and obese subjects with and without
IR are summarized in Tables 1 and 2.
Gender distribution and mean age at admission
were similar in the control, obese with IR, and obese
without IR groups. The obese subjects had
significantly higher ALT, TC, TG, and HARI. Changes
in HARI correlated significantly to changes in BMI,
SDS-BMI, MAC, TSF, MAC, ALT, TC, insulin, and
HOMA-IR (r = 0.578, P = 0.001; r = 0.547, P = 0.001;
r = 0.549, P = 0.001; r = 0.504, P = 0.001; r = 0.549, P
= 0.001; r = 0.223, P = 0.029; r = 0.306, P = 0.002; r =
0.315, P = 0.011; r = 0.295, P = 0.018, respectively,
Table 3). Obese subjects with NAFLD (n = 64) had
significantly higher HARI, insulin, HOMA-IR, ALT,
TG, and TC than the control subjects. Obese subjects

Table 1. Clinical and laboratory findings of obese and control subjects.
Obese with
NAFLD
(n = 64)

Control
(n = 32)

P

13.5 ± 1.36

13.8 ± 1.24

NS

30 / 34

16 / 16

NS*

BMI (kg/m )

30.3 ± 3.13

20.1 ± 1.07

0.001

SDS-BMI

2.6 ± 0.34

0.29 ± 0.49

0.001

Glucose (mg/dL)

89.8 ± 8.5

87.8 ± 6.3

NS

ALT (U/L)

22.9 ± 14.8

16.6 ± 4

0.002

TC (mg/dL)

163.3 ± 29.5

138.4 ± 20.1

0.001

TG (mg/dL)

105.8 ± 39.3

84.7 ± 17.2

0.001

0.7463 ± 0.043

0.6962 ± 0.011

0.001

Age (mean, year ± SD)
Gender (F/M)
2

HARI

Data are given as means ± SD, difference at P < 0.05 level.
BMI, body mass index;
SDS-BMI: body mass index-standard deviation score;
ALT, alanine aminotransferase;
TC, total cholesterol;
TG, triglycerides;
HARI, hepatic artery resistive index;
NS, not significant,
* χ2 test
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Table 2. Clinical and laboratory findings of obese subjects with and without IR.
Obese with
NAFLD and IR
(n = 32)

Obese with
NAFLD without IR
(n = 32)

P

13.4 ± 1.32

13.5 ± 1.43

NS

11 / 21

19 / 13

NS‡

BMI (kg/m )

30.8 ± 3.5

29.8 ± 2.7

NS

SDS-BMI

2.7 ± 0.38

2.6 ± 0.29

NS

TSF (mm)

33.5 ± 8.9

30.9 ± 9.4

NS

MAC (cm)

31.5 ± 3.3

30.8 ± 3.9

NS

Glucose (mg/dL)

90.3 ± 9.2

89.5 ± 8

NS

ALT (U/L)

26.4 ± 17.9

19.6 ± 10

NS

TC (mg/dL)

164.3 ± 29.1

162.4 ± 3.3

NS

TG (mg/dL)

112 ± 43

99.6 ± 34.7

NS

Insulin (mU/mL)

22.7 ± 8.9

7 ± 2.2

0.001

HOMA-IR

6.2 ± 3.7

2.2 ± 0.68

0.001

0.761 ± 0.04

0.732 ± 0.04

0.006

Age (year)
Gender (F/M)
2

HARI

Data are given as means ± SD, difference at P < 0.05 level.
BMI, body mass index;
SDS-BMI, body mass index-standard deviation score;
TSF, triceps skinfold;
MAC, middle arm circumference;
ALT, alanine aminotransferase;
TC, total cholesterol;
TG, triglycerides;
HOMA-IR: homeostasis model assessment for insulin resistance,
HARI, hepatic artery resistive index; NS, not significant;
‡ χ2 test

with NAFLD and IR (n = 32) had significantly higher
HARI compared to obese subjects without IR (n =
32). As an optimal cut-off point, a HARI level of 0.715
determined IR with 81.2% sensitivity and 71.9%
specificity. In the diagnosis of IR, the area under the
curve value was 0.808 ± 0.047 for HARI (P = 0.001).
Positive and negative predictive values and diagnostic
accuracy of this HARI cut-off were 59%, 70%, and
60.6%, respectively.
In the obese group with NAFLD and IR there were
5 subjects with ALT levels higher than the normal
limits but none of them had ALT levels of twice the
upper limit.

Discussion
Obesity is characterized by an impaired direct
vasodilatory effect of insulin on microvasculature
(22). Alteration in endothelial function is a common
underlying event for vascular abnormalities observed
in patients with obesity and IR most likely due to
metabolic and inflammatory responses to the
increased amount of stored fat. This impairment of
endothelial function becomes obvious early on, long
before any vascular abnormalities become clinically
relevant and detectable. Recent studies have shown
that reduced synthesis of vasodilator nitric oxide from
L-arginine in endothelial cells is a major factor
contributing to the impaired action of insulin in the
339
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Table 3. Correlations between HARI, and anthropometric and
laboratory parameters in obese subjects.
Variable

r

P

TSF

0.504

0.001

BMI

0.578

0.001

SDS-BMI

0.547

0.001

TSF

0.549

0.001

MAC

0.549

0.001

ALT

0.223

0.029

TC

0.306

0.002

TG

0.121

NS

Insulin

0.315

0.011

HOMA-IR

0.295

0.018

HARI

BMI, body mass index;
SDS-BMI, body mass index-standard deviation score;
TSF, triceps skinfold;
MAC, middle arm circumference;
ALT, alanine aminotransferase;
TC, total cholesterol;
TG, triglycerides;
HOMA-IR: homeostasis model assessment for insulin resistance,
HARI, hepatic artery resistive index; NS, not significant.

vasculature of obese and diabetic subjects (23). Insulin
derived endothelium-dependent vasorelaxation is
reduced in rats with IR, hyperinsulinemia,
hypertriglyceridemia, hyperlipidemia, and elevated
blood pressure (24). The prevalence of IR is higher in
obese children with NAFLD (25). IR state is an early
sign of hepatic dysfunction in NAFLD (26). Although
the Doppler flow pattern of hepatic veins has been
shown to be altered in an obese population with liver
steatosis (27), little information is available on hepatic
arterial hemodynamics in obese adolescent subjects
with NAFLD and IR. Although clamp techniques
have been applied as a standard approach in the study
of insulin sensitivity and insulin secretion during
childhood, they are too invasive for general
epidemiologic studies, and the HOMA has correlated
well with clamp studies (23).
In the present study, we examined the relation of
HARI evaluated by Doppler ultrasonography with
anthropometric parameters such as BMI, SDS-BMI,
TSF, and MAC, and laboratory parameters such as
ALT, TC, TG, and HOMA-IR. Our results confirmed
340

that ALT, TG, and TC levels and HARI level of obese
subjects with fatty liver are significantly higher than
those of lean subjects. Elevation in HARI level was
also correlated significantly with BMI increase.
Hepatic artery resistive index is a Doppler
ultrasonography parameter used to follow up
microcirculatory resistance in fatty liver, alcoholic
liver disease, chronic hepatitis, obesity, and posttransplant liver adult patients and in children with
severe cirrhosis secondary to biliary atresia (12,1518,27). Little information is available on hepatic
arterial hemodynamics in obese adolescent subjects
with NAFLD and insulin resistant lean subjects, and
similarly, in our study, there was an important
correlation between HARI and age and BMI, which is
compatible with the results of earlier studies (26).
Measurement of HARI may be useful for detection of
the early hemodynamic changes related to liver
dysfunction due to NAFLD and insulin resistant states
in obese children. In the diagnosis of IR, the area
under the curve value was 0.808 ± 0.047 for HARI (P
= 0.001). Using a cut-off point of 0.715, HARI
determined IR with 81.2% sensitivity and 71.9%
specificity with positive and negative predictive values
and diagnostic accuracy of 59%, 70%, and 60.6%
respectively, in the determination of IR. Other
laboratory tests were not significantly different in
obese subjects with IR. Our findings reflect that this
cut-off value has moderate accuracy in differentiating
healthy subjects and individuals with IR. However, the
lower positive and negative predictive values suggest
that HARI cut-off may be used as a preliminary test
for screening purposes. Larger studies with higher
number of patients would be useful for determining
the value of this test for diagnostic purposes.
Nadea et al. (25) and Schwimmer et al. (26)
demonstrated that treatment of IR with metformin
leads to improvement in the severity of fatty liver and
ALT levels. Most of the pathogenetic factors for
NAFLD (obesity, lipid profile changes, inflammation)
are common for IR. Measurement of HARI may be
informative about the microvascular pathology due
to IR and indirect effect of NAFLD and may give a
clue about risk stratification for that subject with fatty
liver. This is the first case control clinical study to
demonstrate the relation of HARI and IR in obese
subjects.
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Our study had a few limitations. First, we did not
evaluate interobserver and intraobserver differences
in measuring HARI. However, we followed strict
guidelines for HARI measurements recommended in
the literature, such as measurements must be done by
a skilled radiologist using the same US equipment
with the same hardware and software in standard
conditions related to the patient (12). Measurements
in this study were done by one skilled radiologist with
the same machine at 1200 after 12 h of fasting in order
to avoid the prandial effect. Another limitation was
that we did not grade the degree of liver steatosis.
Consequently, we did not investigate a possible
relation between severity of steatosis and HARI.

The results of this study confirm the suggestion
that the early recognition of IR and its effects on
hemodynamics of liver is important, since
steatohepatitis progression in NAFLD patients is
strictly related to the presence of IR. In conclusion,
we recommend that HARI be a preliminary
candidate for the detection of early derangement of
hepatic arterial perfusion due to IR. Further studies
with larger series are warranted in order to
determine the utility of HARI for screening and risk
stratification purposes in obese children with
NAFLD for development of IR.
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